Isradipine
- Product NDC
- 68462-807
- 11-digit product format
- 684620807
- Labeler code
- 68462
- Product ID
- 68462-807_02ffa6f4-81c6-45c5-a9fd-a4353ab974ec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Isradipine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Glenmark Pharmaceuticals Inc.,USA
- Application
- ANDA077169
- Marketing category
- ANDA
- Marketing start
- 2014-05-15
- Marketing end
- 0000-00-00
- Substance
- ISRADIPINE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68462-807-01 | 68462080701 | 100 CAPSULE in 1 BOTTLE (68462-807-01) | 100 capsule | 2018-08-31 | 0000-00-00 | No | No | Current |
| 68462-807-05 | 68462080705 | 500 CAPSULE in 1 BOTTLE (68462-807-05) | 500 capsule | 2018-08-31 | 0000-00-00 | No | No | Current |